134 F. Supp. 3d 961
E.D.N.C.2015Background
- Decedent Jarred Sparks, an autistic 19-year-old, died by asphyxiation inside a Vitaeris 320 portable mild hyperbaric chamber on June 10, 2011; the family purchased the used chamber in 2011.
- HTI manufactured the Vitaeris 320 and obtained FDA 510(k) clearance; Oxy-Health (defendant) was HTI’s exclusive U.S. distributor and repackaged bladders with compressors under the Oxy-Health brand.
- The chamber used a single air-supply connection via a Colder quick-disconnect valve; if the valve/hose disengaged or compressor failed, CO2 could accumulate and oxygen flow would cease; no alarm was present.
- Evidence showed Oxy-Health marketed the chamber as its own product (branded packaging, manual, “manufacturer’s warranty,” trade-show promotion), although HTI’s name appeared on the bladder.
- Plaintiffs sued on product-liability theories under N.C. Gen. Stat. ch. 99B (design defect §99B-6; failure-to-warn §99B-5), common-law negligence claims (including NIED), UDPA, and UCC warranty claims; Oxy-Health moved for summary judgment on all claims.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Is Oxy-Health a “manufacturer” under N.C. Gen. Stat. § 99B-1(2)? | Oxy-Health designed/assembled or was the apparent manufacturer via branding, warranty, marketing. | It only repackaged, recommended parts, and lacked control to design or assemble the bladder/product. | Not a legal manufacturer as to design/assembly, but disputed fact exists on "apparent manufacturer" — reasonable jury could find apparent manufacturer. |
| §99B-6 design-defect claim (quick-disconnect and lack of O2 alarm) — liability & causation | Design alternatives (threaded connector, O2 alarm) were feasible and would have reduced risk; expert supports. | Even if defect existed, plaintiffs cannot prove proximate cause because lack of supervision and other intervening acts could have prevented death. | Plaintiffs showed feasibility of alternatives but failed to prove proximate cause; summary judgment for defendant on §99B-6. |
| §99B-5 failure-to-warn — duty & causation | As distributor, Oxy-Health failed to warn of asphyxiation risk from disconnection; on-chamber warnings insufficient. | Distributor duty to warn arises only with actual/constructive knowledge of specific hazard; plaintiffs didn’t read manual and wouldn’t have heeded additional warnings, so no causation. | Plaintiffs cannot show Oxy-Health knew the particular risk or that a warning would have prevented the death; summary judgment for defendant on §99B-5. |
| UDPA claim (misrepresentations re: FDA approval, ASME compliance, safe home use) | Oxy-Health misrepresented approvals/standards and safety for unsupervised home use; plaintiffs relied on these representations. | No actual reliance by purchasers on the alleged misrepresentations; affidavit is inconsistent with deposition and is struck. | Plaintiff’s affidavit is a sham; no evidence of actual reliance — summary judgment for defendant on UDPA. |
| Other negligence/NIED/punitive damages | Emotional-distress and other negligence claims flow from product defect; punitive damages appropriate if willful conduct shown. | These are product-liability claims requiring causation; plaintiffs lack causation and punitive damages require compensatory recovery. | Negligence and NIED fail for lack of causation and foreseeability; punitive damages dismissed because no underlying compensatory recovery. |
Key Cases Cited
- Celotex Corp. v. Catrett, 477 U.S. 317 (summary judgment burden allocation)
- Anderson v. Liberty Lobby, Inc., 477 U.S. 242 (genuine issue for trial standard at summary judgment)
- Matsushita Elec. Indus. Co. v. Zenith Radio Corp., 475 U.S. 574 (summary judgment and inferences)
- Warzynski v. Empire Comfort Systems, Inc., 102 N.C. App. 222 (apparent-manufacturer doctrine applied to distributor marketing/branding)
- DeWitt v. Eveready Battery Co., 355 N.C. 672 (statutory framework for product liability under N.C. Gen. Stat. ch. 99B)
- Bernick v. Jurden, 306 N.C. 435 (malfunction inference and product defect proof)
- Sakaria v. Trans World Airlines, 8 F.3d 164 (proximate-cause standard where multiple intervening factors exist)
- Riegel v. Medtronic, Inc., 552 U.S. 312 (discussion of FDA 510(k) clearance scope)